Share tips of the week
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Three to buy
GlaxoSmithKline
(Shares) GSK’s shares are on a deep discount compared to peer AstraZeneca. They yield 6.5% but analysts think dividend cover next year will be tight. Yet the market is missing key strengths: a robust vaccine division – notably thanks to its Shingrix vaccine – and a “strong pipeline” at the oncology franchise. The consumer healthcare joint venture with Pfizer will also unlock cost savings and better margins. On a price/earnings ratio (p/e) of 11 the stock is appealing. Buy. 1,221p
Hiscox
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
![https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748-320-80.jpg)
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Mail on Sunday) “Should you buy an insurer in the middle of a global catastrophe?” Hiscox is a diversified player, offering everything from “big ticket insurance” of oil rigs to niche retail policies for art and kidnap cover. With Covid-19 striking so broadly this has been a “torrid” year, but recent trading updates suggest the ship is steadying and premium income has kept growing. With the stock down by half since July 2019 Hiscox could prove “a good policy”. 942p
Kingfisher
(Investors Chronicle) Lockdown is no problem for the B&Q and Screwfix-owner, which operates in the UK, France, Poland and Romania. Classified as “essential”, the stores are likely to see a sales surge as housebound Europeans look for something to keep themselves occupied. New management is de-centralising operations to make managers more responsive to local conditions and more people are getting the DIY bug. On 15 times 2022 earnings this is a reasonably-priced turnaround play. Buy. 287p
Three to sell
Dropbox Inc.
(Forbes.com) This cloud-storage specialist reported more than 15 million paying users in the third quarter. Yet its ability to take market share from larger rivals remains in question. The group is struggling to distinguish itself from Google, Apple and Microsoft, which offer more services and are frequently more competitive on price. The shares are priced for implausibly rapid growth. The current valuation implies 46 million paying users by 2027, or 30% of Amazon Prime’s US membership. Given the rich valuation, the risks are tilted to the downside, so avoid. $19
Mercantile Investment Trust
(The Times) This FTSE-250 Trust offers concentrated exposure to the UK market through quality holdings such as Computacenter and Games Workshop. The portfolio is focused on the industrial, financial and consumer sectors but avoids oil and gas. British stocks are trading near 50-year lows and some money managers sense long-term opportunity. Perhaps, but with a double-dip recession looming the FTSE still faces significant headwinds, so all but “the fearless” should avoid. 199p
Ryanair
(The Sunday Telegraph) Ryanair’s latest update showed sales down 78% and a near-€200m after-tax loss over the six months through September. Impressive cost savings and €4.5bn of cash mean that “it will survive” and there will be fewer competitors on the other side of the pandemic. Yet survival is no guarantee of returns, especially with the shares only 14% below their pre-pandemic level. Stick to shares that are less likely to face continued turbulence. €13.34
...and the rest
The Daily Telegraph
Gresham House Strategic Trust has been hoovering up deeply discounted UK micro-cap shares. Patient, risk-tolerant investors could be rewarded when the market turns. Buy (985p). British software “gem” Blancco helps companies delete old data to comply with data-protection laws. It is a leader in this niche and the longer-term growth opportunity is very promising – buy (191p).
Investors Chronicle
US-based Thermo Fisher Scientific is a leading provider of scientific laboratory kit. Business has received a fillip during the coronavirus, while the group should also enjoy a long-term tailwind from rising healthcare spending. Buy ($481).
The Mail on Sunday
Self-storage is a rare bright spot amid the gloom for commercial landlords. Lok’nStore may also gain from the house-buying boom as people need storage space between moves. Hold (565p).
Shares
Newly listed Canadian gold play Wheaton Precious Metals is a “streaming” company – meaning it invests in mining without directly assuming operational risks. There are few comparable businesses on the London market and it offers a new way to buy into the ongoing strength of the yellow metal (3,725p). Microsoft continues to beat analysts’ forecasts thanks to the work-from-home boom, justifying its central role in many a portfolio.Keep buying ($202).
The Times
Packaging firm DS Smith is exposed to the e-commerce boom and on just nine times forecast earnings the shares “look wildly undervalued”.Buy (290p).
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Revolut finally bags a UK banking licence – what next for the fintech?
Revolut has finally been granted a UK banking licence following three years of negotiations with the regulator
By Kalpana Fitzpatrick Published
-
Could Labour impose a “double death tax” of more than 50%?
Speculation is mounting that capital gains tax will be reformed in the Budget - and one option is to charge bereaved families the tax on top of inheritance tax. We explain how it could work
By Ruth Emery Published
-
UK mid-caps: an improving outlook
UK mid-caps have perked up and the rally may run further, but long-term investors should remain selective
By Cris Sholto Heaton Published
-
The tobacco industry is going smoke-free - how to profit from it
Tobacco companies have realised their traditional products are on the wane. But new opportunities have opened up – and should prove lucrative
By Rupert Hargreaves Published
-
Is it time to invest in creative industries?
Any industrial strategy should not overlook the creative industries, one of our top national assets
By David C. Stevenson Published
-
Is Mercia Asset Management set for success?
Mercia Asset Management helps the government fund smaller companies in Britain’s regions. Should you invest?
By Rupert Hargreaves Published
-
British stocks set for a boost
British stocks are due for a bounce as the UK looks more stable compared to many economies
By Alex Rankine Published
-
Ocado shares jump by a fifth
Ocado takes a turn for the better after attractive profit forecasts were announced
By Dr Matthew Partridge Published
-
The AI boom is on borrowed time
The hype around the AI boom could be on its way out – but why?
By Alex Rankine Published
-
Diploma: a blue-chip set for strong growth
Diploma, whose niche products include seals and fasteners, serves an array of growth markets. Should you invest?
By Dr Mike Tubbs Published